A detailed history of Raymond James & Associates transactions in Teleflex Inc stock. As of the latest transaction made, Raymond James & Associates holds 68,990 shares of TFX stock, worth $13.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,990
Previous 70,482 2.12%
Holding current value
$13.2 Million
Previous $14.8 Million 15.08%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$211.25 - $247.28 $315,185 - $368,941
-1,492 Reduced 2.12%
68,990 $17.1 Million
Q2 2024

Jul 19, 2024

SELL
$198.62 - $223.79 $13.7 Million - $15.4 Million
-68,921 Reduced 49.44%
70,482 $14.8 Million
Q1 2024

Apr 22, 2024

BUY
$215.39 - $255.05 $2.84 Million - $3.36 Million
13,176 Added 10.44%
139,403 $31.5 Million
Q4 2023

Jan 16, 2024

BUY
$179.39 - $256.21 $2.14 Million - $3.06 Million
11,943 Added 10.45%
126,227 $31.5 Million
Q3 2023

Oct 24, 2023

SELL
$196.41 - $258.77 $284,598 - $374,957
-1,449 Reduced 1.25%
114,284 $22.4 Million
Q2 2023

Jul 25, 2023

BUY
$232.06 - $274.11 $4.03 Million - $4.76 Million
17,350 Added 17.64%
115,733 $28 Million
Q1 2023

Apr 14, 2023

BUY
$222.88 - $262.22 $6.84 Million - $8.05 Million
30,685 Added 45.33%
98,383 $24.9 Million
Q4 2022

Feb 08, 2023

SELL
$188.57 - $253.75 $216,478 - $291,305
-1,148 Reduced 1.67%
67,698 $16.9 Million
Q3 2022

Oct 25, 2022

SELL
$201.46 - $267.32 $1.65 Million - $2.19 Million
-8,185 Reduced 10.63%
68,846 $13.9 Million
Q2 2022

Aug 12, 2022

SELL
$244.93 - $354.82 $212,109 - $307,274
-866 Reduced 1.11%
77,031 $18.9 Million
Q1 2022

May 11, 2022

SELL
$295.56 - $354.83 $501,860 - $602,501
-1,698 Reduced 2.13%
77,897 $27.6 Million
Q4 2021

Feb 08, 2022

SELL
$289.48 - $383.27 $4.04 Million - $5.35 Million
-13,971 Reduced 14.93%
79,595 $26.1 Million
Q3 2021

Nov 02, 2021

SELL
$360.3 - $422.82 $2.51 Million - $2.95 Million
-6,980 Reduced 6.94%
93,566 $35.2 Million
Q2 2021

Aug 11, 2021

BUY
$385.96 - $443.85 $68,700 - $79,005
178 Added 0.18%
100,546 $40.4 Million
Q1 2021

May 14, 2021

BUY
$372.25 - $429.44 $1.69 Million - $1.95 Million
4,537 Added 4.73%
100,368 $41.7 Million
Q4 2020

Feb 12, 2021

BUY
$318.23 - $411.57 $6.58 Million - $8.51 Million
20,684 Added 27.52%
95,831 $39.4 Million
Q3 2020

Nov 04, 2020

BUY
$326.7 - $408.18 $905,612 - $1.13 Million
2,772 Added 3.83%
75,147 $25.6 Million
Q2 2020

Jul 28, 2020

BUY
$279.8 - $376.58 $1.22 Million - $1.65 Million
4,369 Added 6.42%
72,375 $26.3 Million
Q1 2020

Apr 21, 2020

BUY
$225.31 - $395.14 $2.42 Million - $4.24 Million
10,719 Added 18.71%
68,006 $19.9 Million
Q4 2019

Feb 12, 2020

SELL
$316.75 - $376.44 $467,839 - $556,001
-1,477 Reduced 2.51%
57,287 $21.6 Million
Q3 2019

Nov 07, 2019

SELL
$329.13 - $371.65 $643,449 - $726,575
-1,955 Reduced 3.22%
58,764 $20 Million
Q2 2019

Aug 06, 2019

BUY
$274.54 - $336.13 $2.01 Million - $2.46 Million
7,322 Added 13.71%
60,719 $20.1 Million
Q1 2019

May 06, 2019

BUY
$246.2 - $304.96 $136,641 - $169,252
555 Added 1.05%
53,397 $16.1 Million
Q4 2018

Feb 11, 2019

SELL
$229.54 - $275.63 $660,386 - $792,987
-2,877 Reduced 5.16%
52,842 $13.7 Million
Q3 2018

Nov 14, 2018

BUY
$228.13 - $278.9 $1.07 Million - $1.31 Million
4,710 Added 9.23%
55,719 $14.8 Million
Q2 2018

Aug 14, 2018

BUY
$246.68 - $284.87 $238,046 - $274,899
965 Added 1.93%
51,009 $13.7 Million
Q1 2018

May 14, 2018

BUY
$242.67 - $287.65 $1.02 Million - $1.2 Million
4,185 Added 9.13%
50,044 $12.8 Million
Q4 2017

Feb 14, 2018

SELL
$236.76 - $270.19 $725,906 - $828,402
-3,066 Reduced 6.27%
45,859 $11.4 Million
Q3 2017

Nov 13, 2017

BUY
$203.01 - $242.56 $249,499 - $298,106
1,229 Added 2.58%
48,925 $11.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
47,696
47,696 $9.91 Million

Others Institutions Holding TFX

About TELEFLEX INC


  • Ticker TFX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,906,400
  • Market Cap $8.96B
  • Description
  • Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access ...
More about TFX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.